Shield Therapeutics plc (AIM:STX)

Shield Therapeutics Statistics

Total Valuation

AIM:STX has a market cap or net worth of GBP 76.44 million. The enterprise value is 88.29 million.

Market Cap	76.44M
Enterprise Value	88.29M

Important Dates

The last earnings date was Friday, September 5, 2025.

Earnings Date	Sep 5, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM:STX has 1.06 billion shares outstanding. The number of shares has increased by 19.74% in one year.

Current Share Class	1.06B
Shares Outstanding	1.06B
Shares Change (YoY)	+19.74%
Shares Change (QoQ)	+32.96%
Owned by Insiders (%)	1.71%
Owned by Institutions (%)	30.39%
Float	405.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.52
PB Ratio	-7.05
P/TBV Ratio	n/a
P/FCF Ratio	20.73
P/OCF Ratio	20.73
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.70
EV / Sales	2.92
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	23.94

Financial Position

The company has a current ratio of 0.83

Current Ratio	0.83
Quick Ratio	0.69
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	5.35
Interest Coverage	-2.43

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-16.77%
Return on Invested Capital (ROIC)	-55.83%
Return on Capital Employed (ROCE)	-120.79%
Revenue Per Employee	480,749
Profits Per Employee	-246,069
Employee Count	63
Asset Turnover	0.76
Inventory Turnover	3.98

Taxes

In the past 12 months, AIM:STX has paid 573,701 in taxes.

Income Tax	573,701
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.17% in the last 52 weeks. The beta is 1.27, so AIM:STX's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	+44.17%
50-Day Moving Average	6.38
200-Day Moving Average	3.72
Relative Strength Index (RSI)	45.93
Average Volume (20 Days)	5,497,831

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:STX had revenue of GBP 30.29 million and -15.50 million in losses. Loss per share was -0.02.

Revenue	30.29M
Gross Profit	14.64M
Operating Income	-10.66M
Pretax Income	-14.93M
Net Income	-15.50M
EBITDA	-10.49M
EBIT	-10.66M
Loss Per Share	-0.02

Balance Sheet

The company has 7.89 million in cash and 19.74 million in debt, giving a net cash position of -11.85 million or -0.01 per share.

Cash & Cash Equivalents	7.89M
Total Debt	19.74M
Net Cash	-11.85M
Net Cash Per Share	-0.01
Equity (Book Value)	-10.84M
Book Value Per Share	-0.01
Working Capital	-6.31M

Cash Flow

In the last 12 months, operating cash flow was 3.69 million and capital expenditures -730, giving a free cash flow of 3.69 million.

Operating Cash Flow	3.69M
Capital Expenditures	-730
Free Cash Flow	3.69M
FCF Per Share	0.00

Margins

Gross margin is 48.34%, with operating and profit margins of -35.20% and -51.18%.

Gross Margin	48.34%
Operating Margin	-35.20%
Pretax Margin	-49.29%
Profit Margin	-51.18%
EBITDA Margin	-34.65%
EBIT Margin	-35.20%
FCF Margin	12.17%

Dividends & Yields

AIM:STX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.74%
Shareholder Yield	n/a
Earnings Yield	-20.28%
FCF Yield	4.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AIM:STX has an Altman Z-Score of -6.08 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.08
Piotroski F-Score	4